Category Matches
- 100-200 Tests
- 125 mg
- 125 Tests
- 2 mg
- 2 Plates
- 2-BHA
- 2-Deoxy-D-Glucose
- 2-deoxy-D-glucose
- 2-DG
- 2.5 mg
- 20 g
- 20 mg
- 20 Tests
- 200 Tests
- 200 µg
- 24 Tests
- 25 g
- 25 mg
- 25 ml
- 25 Tests
- 25 µg
- 25-250 Tests
- 25-50 Tests
- 250 g
- 250 mg
- 250 ml
- 250 Tests
- 250 µg
- 250mg
- 25g
- 25mg
- 2BHA
- 5-bromo-2'-deoxyuridine
- 5-HT2 Receptors - Analgesics
- 5-HT2 Receptors - Antidepressant
- 5-HT2 Receptors - Antipsychotic
- 5-HT2 Receptors - Anxiolytic
- 5-HT2 Receptors - Cognition Enhancing
- 5-HT2 Receptors - Hypnotics
- 5-HT2 Receptors - Neurodegenerative Diseases
- 5-HT2 Receptors - Sedatives
- AMG-925
- Antimicrobial Peptides - Natural Products
- arv825
- AZD-1152
- AZD-1152-HQPA
- AZD-1208
- AZD-9291
- B02
- BAY1816032
- Bcl-2
- Biochemicals
- BIX01294
- BML-275
- Ca2+ Channel Blockers - Anti-anginal
- Ca2+ Channel Blockers - Antihypertensive
- Ca2+ Channel Blockers - Vasodilatory
- Ca2+ Channels - Analgesics
- Ca2+ Channels - Anesthetic
- Ca2+ Channels - Antidepressant
- Ca2+ Channels - Antiepileptics and Anticonvulsants
- Ca2+ Channels - Antipsychotic
- Ca2+ Channels - Anxiolytic
- Ca2+ Channels - Cognition Enhancing
- Ca2+ Channels - Sedatives
- Ca2+ Ion Channels - Neurodegenerative Diseases
- Ca2+-sensing Receptors - Neurodegenerative Diseases
- Category Menu
- CCT-245737
- CEP-28122
- CHIR99021
- Chk1/2
- Class IV (Ca2+ Channel Blocker)
- COX-2
- COX-2 - Analgesics
- CPI-203
- D2 Receptor Antagonists
- D2 Receptors - Analgesics
- D2 Receptors - Anesthetic
- D2 Receptors - Antidepressant
- D2 Receptors - Antipsychotic
- D2 Receptors - Anxiolytic
- D2 Receptors - Cognition Enhancing
- D2 Receptors - Neurodegenerative Diseases
- D2 Receptors - Sedatives
- EIDD-2801
- EIDD2801
- eIF2B - Cognition Enhancing
- eIF2B - Neurodegenerative Diseases
- EZH2 Histone Methyltransferase
- GBR-12935
- GDC-0032
- GSK-429286A
- Indoleamine 2,3-dioxygenase
- ITF-2357
- K252a
- K252b
- K252c
- LMK-235
- lmk235
- LRRK2 - Neurodegenerative Diseases
- lx2343
- LY-2606368
- LY2606368
- M2 Protein Inhibitors
- MDM2
- Natural Products
- Neuroscience
- Neurotoxins
- New Products
- NMS-E628
- NSAIDs: COX-2 Inhibitors
- nu2058
- Other Products
- P2Y12
- PF-07321332
- PIK-294
- PKC412
- rated-2
- SARS-CoV-2
- SARS-CoV2
- SB-203580
- SB-431542
- SNS-032
- su5402
- UNC0064-12
- VE821
- VE822
- XL-228
- α2-adrenergic Receptor Agonists
Product Matches
- Welcome to the new lktlabs.com!Welcome to the new lktlabs.com! The long process of updating and improving our w...
- B7118Brevetoxin 3 42-carboxylic Acid
Polyether neurotoxin found in Karenia brevis; Nav1.4/1.5 Na+ channel activato...
≥95% - B6916Brevetoxin 1
Polyether neurotoxin found in Karenia brevis; Nav1.4/1.5 Na+ channel activato...
≥95% - B6918Brevetoxin 3
Polyether neurotoxin found in Karenia brevis; Nav1.4/1.5 Na+ channel activato...
≥95% - B6917Brevetoxin 2
Polyether neurotoxin found in Karenia brevis; Nav1.4/1.5 Na+ channel activato...
≥95% - M3407Microcystin-RR
Cyclic heptapeptide produced by Microcystis; PP1/2A inhibitor, potential GSK-...
≥95% - M3406Microcystin-LR
Cyclic heptapeptide produced by Microcystis; PP1/2A inhibitor, potential GSK-...
≥95% - T1878Tetrodotoxin Citrate
Neurotoxin found in puffer fish; site 1 voltage-gated Na+ channel blocker.
≥99% - A0958Aconitine
Toxin found in Aconitum; voltage-gated Na+ channel modulator.
≥95% - B8144Bulleyaconitine A
Found in Aconitum bulleyanum; voltage-gated Na+ channel blocker.
≥95% - L0060Lappaconitine
Alkaloid originally found in species of Aconitum; cardiac Na+ channel blocker...
≥95% - A4849Amyloid-β (25-35)
Endogenous APP peptide cleavage product, primary component in amyloid plaques...
≥95% - A4848Amyloid-β (1-40)
Endogenous APP peptide cleavage product, primary component in amyloid plaques...
≥98% - A0249BAM-22P
Peptide, cleavage product of proenkephalin; κOR and μOR agonist.
≥95% - A0248BAM-12P
Peptide, cleavage product of proenkephalin; κOR agonist.
≥95% - A4854β-Amyloid Peptide (1-42), rat
Endogenous APP peptide cleavage product, primary component in amyloid plaques...
≥95% - A4853β-Amyloid Peptide (1-42), human
Endogenous APP peptide cleavage product, primary component in amyloid plaques...
≥95% - A4852β-Amyloid Peptide (1-40)
Endogenous APP peptide cleavage product, primary component in amyloid plaques...
≥95% - A4851β-Amyloid Peptide (1-40), rat
Endogenous APP peptide cleavage product, primary component in amyloid plaques...
≥95% - H981425-Hydroxyvitamin D2
Vitamin D2, ergocalciferol metabolite; VDR agonist.
≥98%